{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06113237",
            "orgStudyIdInfo": {
                "id": "GWEP21095"
            },
            "organization": {
                "fullName": "Jazz Pharmaceuticals",
                "class": "INDUSTRY"
            },
            "briefTitle": "Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy",
            "officialTitle": "Observational Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy to Assess the Risk of Pregnancy and Maternal Complications and Other Events of Interest on the Developing Fetus, Neonate, and Infant",
            "therapeuticArea": [
                "Women's Health",
                "Other"
            ],
            "study": "pregnancy-surveillance-program-of-patients-exposed-to-epidiolex-epidyolex-during-pregnancy"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-08-30",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2033-08-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2033-08-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-10-27",
            "studyFirstSubmitQcDate": "2023-10-27",
            "studyFirstPostDateStruct": {
                "date": "2023-11-02",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Jazz Pharmaceuticals",
                "class": "INDUSTRY"
            }
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to evaluate pregnancy-related health outcomes in participants who are exposed to Epidiolex/Epidyolex during pregnancy and their infant up to 12 months of life."
        },
        "conditionsModule": {
            "conditions": [
                "Maternal Complications",
                "Pregnancy Complication",
                "Birth Outcomes, Adverse",
                "Pregnancy"
            ],
            "keywords": [
                "Epidiolex",
                "Epidyolex"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 50,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Retrospective Pregnancy",
                    "description": "Participants who were exposed to at least one dose of Epidiolex/Epidyolex in routine practice during the 13 days prior to last menstrual period (LMP) or at any time during their pregnancy and is no longer pregnant at the time of study enrollment.",
                    "interventionNames": [
                        "Drug: Epidiolex"
                    ]
                },
                {
                    "label": "Prospective Pregnancy",
                    "description": "Participants who were exposed to at least one dose of Epidiolex/Epidyolex in routine practice during the 13 days prior to last menstrual period (LMP) or at any time during their pregnancy and is pregnant at the time of study enrollment.",
                    "interventionNames": [
                        "Drug: Epidiolex"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Epidiolex",
                    "description": "Oral solution",
                    "armGroupLabels": [
                        "Prospective Pregnancy",
                        "Retrospective Pregnancy"
                    ],
                    "otherNames": [
                        "Epidyolex",
                        "Cannabidiol"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Rate of MCM",
                    "description": "Rate of Major congenital malformation (MCM) identified in the developing neonate and infant through 12 months of age",
                    "timeFrame": "Up to 12 months post birth"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Rate of pregnancy outcomes",
                    "description": "Rate of the following pregnancy outcomes:\n\n1. Spontaneous abortion\n2. Elective or therapeutic abortion\n3. Fetal death/stillbirth\n4. Molar or ectopic pregnancy\n5. Preterm delivery\n6. Live birth",
                    "timeFrame": "Up to 10 months gestation"
                },
                {
                    "measure": "Rate of other events of interest in the developing neonate and infant",
                    "description": "Rate of the following other events of interest in the developing neonate and infant:\n\n1. Hospitalizations for serious illness\n2. Medications\n3. Growth and development milestones\n4. Neonatal or infant mortality\n5. Inherited epilepsy syndrome",
                    "timeFrame": "Up to 12 months post birth"
                },
                {
                    "measure": "Rate of maternal complications during pregnancy",
                    "description": "Rate of the following maternal complications during pregnancy:\n\n1. Premature rupture of membranes (PROM)\n2. Pre-eclampsia\n3. Severe pregnancy-induced hypertension\n4. Proteinuria\n5. Gestational diabetes\n6. Intrauterine growth restriction (IUGR)\n7. Measures of fetal growth deficiency (small for gestational age)",
                    "timeFrame": "Up to 10 months gestation"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Patients with exposure to at least 1 dose of Epidiolex/Epidyolex during the 13 days prior to their LMP or at any time during pregnancy.\n2. Verbal or written informed consent to participate\n\nExclusion criteria:\n\n1) Patients exposed to a non-regulatory approved product containing Cannabidiol (CBD) during pregnancy who do not also have exposure to Epidiolex during the 13 days prior to their LMP or during the pregnancy.",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Participants who were exposed to at least one dose of Epidiolex/Epidyolex during the 13 days prior to last menstrual period (LMP) or at any time during their pregnancy.",
            "samplingMethod": "PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Clinical Trial Disclosure & Transparency",
                    "role": "CONTACT",
                    "phone": "215-832-3750",
                    "email": "ClinicalTrialDisclosure@JazzPharma.com"
                }
            ],
            "locations": [
                {
                    "facility": "United Biosource LLC",
                    "status": "RECRUITING",
                    "city": "Morgantown",
                    "state": "West Virginia",
                    "zip": "26508",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.62953,
                        "lon": -79.9559
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011248",
                    "term": "Pregnancy Complications"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "asFound": "Pregnancy Complications",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002185",
                    "term": "Cannabidiol"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000927",
                    "term": "Anticonvulsants"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5445",
                    "name": "Cannabidiol",
                    "asFound": "Incentive",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M4246",
                    "name": "Anticonvulsants",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "AntiConv",
                    "name": "Anticonvulsants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                }
            ]
        }
    },
    "hasResults": false
}